Teva Pharmaceuticals (TEVA) ADR

Sell:$17.05Buy:$17.06$0.28 (1.59%)

Prices delayed by at least 15 minutes
Sell:$17.05
Buy:$17.06
Change:$0.28 (1.59%)
Deal now
Prices delayed by at least 15 minutes
Sell:$17.05
Buy:$17.06
Change:$0.28 (1.59%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Key people

Richard D. Francis
President, Chief Executive Officer, Director
Eliyahu Sharon Kalif
Chief Financial Officer, Executive Vice President
Richard Daniell
Executive Vice President - European Commercial
Christine Fox
Executive Vice President - U.S. Commercial
Angus Grant
Executive Vice President - Business Development
Eric A. Hughes
Executive Vice President - Global R & D, Chief Medical Officer
David R. McAvoy
Executive Vice President, Chief Legal Officer
Mark Sabag
Executive Vice President - International Markets Commercial
Matthew Shields
Executive Vice President - Global Operations
Vikki Conway
Acting Head of Global Human Resources
Sol J. Barer
Independent Chairman of the Board
Rosemary A. Crane
Independent Director
Amir Elstein
Independent Director
Chen Lichtenstein
Independent Director
Gerald M. Lieberman
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Israel
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US8816242098
  • Market cap
    $20.29bn
  • Employees
    35,001
  • Shares in issue
    1.24bn
  • Exchange
    Tel Aviv Stock Exchange
  • Index
    TR Equity Israel Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.